Home

Articles from FUJIFILM Healthcare Americas Corporation

Fujifilm to Highlight Cutting-Edge Imaging Innovations at RSNA 2025
FUJIFILM Healthcare Americas Corporation, a leader in diagnostic and enterprise imaging solutions, will highlight its latest diagnostic imaging innovations in booth #3300 in South Hall at the Radiological Society of North America (RSNA) 2025 annual meeting, held November 30 to December 3 at McCormick Place in Chicago. These new imaging advances are built for today’s demanding clinical environments, delivering intelligent mobile bedside imaging, unique Deep Learning MRI applications, high resolution surgical guidance and fully automated radiographic room efficiency.
Fujifilm to Demonstrate Advances in AI Utilization, Speed and Automation in Enterprise Imaging Workflows at RSNA 2025
FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, will showcase new innovations in its industry leading Synapse medical informatics portfolio at the 2025 Radiological Society of North America (RSNA) Conference & Annual Meeting held November 30 to December 3. The new innovations in booth #3300 include a comprehensive enterprise imaging and informatics solution designed to meet the demands of outpatient imaging centers, and updates to Fujifilm’s flagship Synapse Enterprise PACS.
Fujifilm to Unveil Synapse One, a Comprehensive Enterprise Imaging and Informatics Solution Tailored to Meet the Demands of Outpatient Imaging Centers, at RSNA 2025
FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, today announced the launch of Synapse One, a comprehensive, tailor-made workflow solution designed for unique outpatient imaging needs, in North America*. This all-inclusive enterprise imaging solution enables providers to address everything from patient engagement portal, self-scheduling of exams, RIS (Radiology Information System), advanced scheduling capability, RCM options, PACS (Picture Archiving and Communication System), advanced 3D imaging, physician portal, and more, all within the Synapse platform in the secure Amazon Web Services (AWS) cloud. Fujifilm’s experts will be showcasing Synapse One for the first time at booth #3300 in South Hall at the 2025 Radiological Society of North America (RSNA) Conference & Annual Meeting held November 30 to December 3.
Fujifilm Launches Next-Generation ELUXEO® Endoscopic Imaging System with Enhanced LED Multi-Light Technology
FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, and the pioneer of endoscopic LED multi-light technology in the US, announces the launch of its advanced endoscopy platform, the ELUXEO® 8000 Endoscopic Imaging System — a smartly designed single-unit processor and light source (EP-8000) featuring several features that enhance endoscopic image quality, therapeutic capabilities, and workflow efficiencies. The next-generation platform will be demonstrated at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting held October 26 – 28 at the Phoenix Convention Center in Phoenix, Arizona.
Fujifilm and Beekley Medical® Host 2nd Annual Breast Imaging Education Summit
Leading into Breast Cancer Awareness Month, FUJIFILM Healthcare Americas Corporation, a leading provider of medical imaging and informatics solutions, and Beekley Medical®, a leading supplier of niche medical products, hosted its second annual Breast Imaging Education Summit at Fujifilm’s Valhalla, NY headquarters on September 20-21. The complimentary event was well attended and convened radiologic technologists specializing in breast imaging and industry leaders within the field, with attendees earning 13 CE (Continuing Education) credits.
Fujifilm Forges Partnership with PRECIDX to Make Digital Pathology More Accessible to U.S. Health Systems
FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, and PRECIDX, a healthcare data optimization company, have partnered to integrate Fujifilm’s Synapse ® Pathology solution with the PRECIDX Optimization Platform (POP) to reduce digital pathology file storage by an unprecedented 85% [1]contributing to lower storage costs for providers, improved workflow, and expanded access to critical data.
Large East Coast Health System Selects Fujifilm and Amazon Web Services to Transform Pathology Delivery and Diagnosis
FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced that a leading health system with hospital sites spanning five different geographic regions on the East Coast has selected Fujifilm’s Synapse ® Pathology solution and Amazon Web Services (AWS) to transform their pathology delivery and reduce diagnosis timelines through digitalization. The implementation of Synapse Pathology will take place across the health system’s five sites, supported by a fully cloud-based infrastructure using AWS.
Fujifilm Launches FDR Go iQ Portable Digital Radiography System
FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced the U.S. launch of the FDR Go iQ, an innovative portable digital radiography (DR) solution built for hospitals and ambulatory surgery centers. Equipped with intuitive touchscreen controls and a display at the tube head, as well as convenient built-in smart charging, technologists can acquire x-ray room image quality at the patient bedside.
Fujifilm Releases Intelligent Automation Features for the FDR Visionary Suite Digital Radiography Room
FUJIFILM Healthcare Americas Corporation, a leading provider of medical imaging and informatics solutions, today announced the launch of several advanced automated functions for its FDR Visionary Suite digital radiography room. Optimized to support high-volume imaging in hospital radiology departments and imaging centers, the automation features are designed to enhance workflow and improve the patient and technologist experience for a wide range of general radiology exams.
Multi-Center NIH Research Trial Evaluating GALAD, a Novel Blood-Based Algorithm, in the Early Detection of Liver Cancer
FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced today that use of its AFP-L3 and DCP in vitro diagnostic tests is being evaluated in the National Liver Cancer Screening Trial (known as TRACER), a study funded by the National Cancer Institute, part of the National Institute of Health. The multi-center study compares liver cancer screening strategies in patients with cirrhosis or chronic hepatitis B.
Fujifilm Strengthens Partnership with the National Rural Health Association to Improve Access to Medical Imaging in Rural Communities
FUJIFILM Healthcare Americas Corporation, a leading provider of medical imaging and informatics solutions, announces that it has strengthened its partnership with the National Rural Health Association (NRHA) to help improve access to medical imaging in rural areas. Selected as a Platinum Partner by NRHA for a second 3-year term, Fujifilm is recognized for its leadership and dedication in providing products and services tailored for rural communities spanning MRI, CT, ultrasound, mammography, digital radiography, endoscopy, and enterprise imaging.
Fujifilm’s EN-840T Double Balloon Enteroscopy Scope Wins 2025 MedTech Breakthrough Award
FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, announced that its EN-840T Double Balloon Enteroscopy (DBE) Scope, an endoscopic imaging technology that enables access to the entire small intestine for diagnosis and therapeutic intervention, has been selected as the winner of the “Best New Endoscopy Technology Solution” award in the 9th annual MedTech Breakthrough Awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.
Fujifilm Announces the Commercialization of Two New Gastroscopes for Its 800 Series Portfolio at the Digestive Disease Week (DDW®) 2025 Conference
FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, today announced the commercialization of the EG-840T treatment gastroscope and the EG-840TP slim treatment gastroscope. The gastroscopes are part of Fujifilm’s next-generation 800 series portfolio and are powered by Fujifilm’s ELUXEO® Endoscopic Imaging System, which features LED multi-light technology for enhanced visualization. Both gastroscopes will be publicly demonstrated for the first time at the 2025 Digestive Disease Week (DDW®) annual conference and exhibition in booth 4729, held May 4-6 in San Diego.
Fujifilm Demonstrates State-of-the-Art Endoscopic Imaging Technology at the Digestive Disease Week (DDW®) 2025 Conference
FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, will showcase its industry leading endoscopic imaging technology portfolio, including two recently announced new state-of-the-art gastroscopes, next generation double balloon enteroscopy scope, as well as the latest endoscopic ultrasound (EUS) and Third Space Endoscopy innovations in booth #4729 at the 2025 Digestive Disease Week (DDW®) annual conference and exhibition annual meeting held May 4-6 in San Diego.
Fujifilm Partners with Us2.ai to Provide AI-Automated Echocardiography Analysis for Cardiologists and Sonographers Across the Nation
FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions and Us2.ai, a leader in AI-automated echocardiography solutions, have partnered to equip Fujifilm’s LISENDO 800 cardiovascular ultrasound system with Us2.ai's artificial intelligence (AI)-driven, automated clinical workflow solution. Us2.ai’s software, when used with the LISENDO 880 ultrasound system, fully automates the analysis and reporting of echocardiograms and provides comprehensive cardiac measurements for the diagnosis of heart disease.